NCT02187263

Brief Summary

This is a joint project by Heidelberg University and Greifswald University. Our objective is to establish an unique national multi-center registry and biobank of well phenotyped patients with non-ischemic cardiomyopathies (CMP) including in depth clinical, molecular and omics-based phenotyping to serve as:

  1. 1.central hub for clinical outcome studies.
  2. 2.joint resource for diagnostic and therapeutic trials.
  3. 3.common biomaterial bank.
  4. 4.resource for detailed molecular analyses on patients' biomaterials and patient specific model systems.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 10, 2014

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

March 25, 2016

Status Verified

March 1, 2016

Enrollment Period

2 years

First QC Date

July 8, 2014

Last Update Submit

March 24, 2016

Conditions

Keywords

hereditary cardiomyopathy,inflammatory cardiomyopathy,registry,biomaterial,clinical trialPatients

Outcome Measures

Primary Outcomes (1)

  • Time to Disease Progression

    12 months

Study Arms (6)

hereditary DCM

inflammatory DCM

LVNC

HCM

ARVC

acute myocarditis

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hereditary and inflammatory cardiomyopathies

You may qualify if:

  • Patients with primary non-ischemic cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, left ventricular non-compaction cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and acute myocarditis.

You may not qualify if:

  • Preexisting other cardiac diseases such as significant valvular, ischemic or pericardial disease; Severe arterial hypertension; Primary pulmonary artery hypertension; Chronic advanced disorders; History of treatment with cardiotoxic agents and chest radiation; Drug and alcohol abuse; Patients \<18 and \>79 years of age; Life expectancy less than 1 year due to non-cardiac comorbidity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Heidelberg

Heidelberg, Germany

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

EDTA, serum, urine

MeSH Terms

Conditions

Cardiomyopathy, DilatedCardiomyopathy, HypertrophicAmyloidosis

Condition Hierarchy (Ancestors)

CardiomegalyHeart DiseasesCardiovascular DiseasesCardiomyopathiesLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAortic Stenosis, SubvalvularAortic Valve StenosisAortic Valve DiseaseHeart Valve DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Hugo A Katus, MD

    Heidelberg University

    STUDY CHAIR
  • Wolfgang Hoffmann, MD

    Department for Community Medicine, University Medicine Greifswald

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2014

First Posted

July 10, 2014

Study Start

December 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2017

Last Updated

March 25, 2016

Record last verified: 2016-03

Locations